Intuitive Surgical Inc tiene un precio objetivo de consenso de $530 basado en las calificaciones de 25 analistas. El máximo es $675, emitido por JP Morgan el enero 24, 2025. El mínimo es $318, emitido por HSBC el noviembre 17, 2023. Las 3 calificaciones de analistas más recientes fueron publicadas por UBS, Raymond James y Piper Sandler el octubre 23, 2025, octubre 22, 2025 y octubre 22, 2025, respectivamente. Con un precio objetivo promedio de $604.33 entre UBS, Raymond James y Piper Sandler, hay una 6.73% upside implícita para Intuitive Surgical Inc según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/23/2025 | 5.96% | UBS | $585 → $600 | Maintains | Neutral | |||
10/22/2025 | 6.49% | Raymond James | $592 → $603 | Maintains | Outperform | |||
10/22/2025 | 7.73% | Piper Sandler | $595 → $610 | Reiterates | Overweight → Overweight | |||
10/22/2025 | 10.38% | RBC Capital | $615 → $625 | Maintains | Outperform | |||
10/22/2025 | 9.49% | Truist Securities | $525 → $620 | Maintains | Buy | |||
10/22/2025 | 5.96% | Wells Fargo | $599 → $600 | Maintains | Overweight | |||
10/22/2025 | 4.02% | BTIG | $529 → $589 | Maintains | Buy | |||
10/15/2025 | -7.28% | Truist Securities | $600 → $525 | Maintains | Buy | |||
10/13/2025 | -6.58% | BTIG | $571 → $529 | Maintains | Buy | |||
10/07/2025 | -20.53% | Evercore ISI Group | $535 → $450 | Maintains | In-Line | |||
10/01/2025 | 0.84% | BTIG | $571 → $571 | Reiterates | Buy → Buy | |||
08/19/2025 | 8.61% | RBC Capital | $615 → $615 | Reiterates | Outperform → Outperform | |||
07/23/2025 | 3.31% | UBS | $547 → $585 | Maintains | Neutral | |||
07/23/2025 | 5.08% | Piper Sandler | $575 → $595 | Reiterates | Overweight → Overweight | |||
07/23/2025 | 5.96% | Truist Securities | $590 → $600 | Maintains | Buy | |||
07/23/2025 | 8.61% | RBC Capital | $605 → $615 | Maintains | Outperform | |||
07/23/2025 | 5.78% | Wells Fargo | $559 → $599 | Maintains | Overweight | |||
07/23/2025 | 0.84% | BTIG | $566 → $571 | Maintains | Buy | |||
07/08/2025 | -2.87% | Evercore ISI Group | $470 → $550 | Maintains | In-Line | |||
06/09/2025 | -22.3% | Deutsche Bank | $515 → $440 | Downgrade | Hold → Sell | |||
05/22/2025 | 14.79% | Citigroup | $590 → $650 | Maintains | Buy | |||
04/24/2025 | 12.14% | Barclays | $684 → $635 | Maintains | Overweight | |||
04/23/2025 | 6.84% | RBC Capital | $630 → $605 | Maintains | Outperform | |||
04/23/2025 | 4.19% | Truist Securities | $605 → $590 | Maintains | Buy | |||
04/23/2025 | 1.55% | Piper Sandler | $670 → $575 | Maintains | Overweight | |||
04/23/2025 | -17% | Evercore ISI Group | $510 → $470 | Maintains | In-Line | |||
04/23/2025 | 1.55% | Baird | $600 → $575 | Maintains | Outperform | |||
03/18/2025 | 5.96% | Baird | $707 → $600 | Maintains | Outperform | |||
03/17/2025 | 6.84% | Truist Securities | $666 → $605 | Maintains | Buy | |||
01/24/2025 | 3.31% | Deutsche Bank | $505 → $585 | Maintains | Hold | |||
01/24/2025 | 17.62% | Truist Securities | $640 → $666 | Maintains | Buy | |||
01/24/2025 | 21.5% | Raymond James | $560 → $688 | Maintains | Outperform | |||
01/24/2025 | 18.32% | Piper Sandler | $538 → $670 | Reiterates | Overweight → Overweight | |||
01/24/2025 | 21.32% | Wells Fargo | $630 → $687 | Maintains | Overweight | |||
01/24/2025 | 25.56% | Citigroup | $640 → $711 | Maintains | Buy | |||
01/24/2025 | 19.21% | JP Morgan | $575 → $675 | Maintains | Overweight | |||
12/18/2024 | 13.02% | Truist Securities | $570 → $640 | Maintains | Buy | |||
12/11/2024 | 13.02% | Citigroup | $567 → $640 | Maintains | Buy | |||
12/11/2024 | 11.26% | Wells Fargo | $549 → $630 | Maintains | Overweight | |||
12/05/2024 | 7.73% | Stifel | $525 → $610 | Maintains | Buy | |||
12/02/2024 | 14.79% | Morgan Stanley | $522 → $650 | Upgrade | Equal-Weight → Overweight | |||
11/26/2024 | -0.93% | BTIG | $535 → $561 | Maintains | Buy | |||
11/19/2024 | — | Erste Group | — | Upgrade | Hold → Buy | |||
10/18/2024 | -13.47% | Evercore ISI Group | $475 → $490 | Maintains | In-Line | |||
10/18/2024 | -5.52% | BTIG | $518 → $535 | Maintains | Buy | |||
10/18/2024 | -4.99% | Piper Sandler | $495 → $538 | Reiterates | Overweight → Overweight | |||
10/18/2024 | -7.28% | Stifel | $475 → $525 | Maintains | Buy | |||
10/18/2024 | -3.05% | Wells Fargo | $466 → $549 | Maintains | Overweight | |||
10/18/2024 | -1.99% | RBC Capital | $525 → $555 | Maintains | Outperform | |||
10/18/2024 | -0.22% | Baird | $503 → $565 | Maintains | Outperform | |||
10/14/2024 | -4.64% | Raymond James | $500 → $540 | Maintains | Outperform | |||
10/14/2024 | -8.52% | BTIG | $494 → $518 | Maintains | Buy | |||
10/14/2024 | 0.66% | Truist Securities | $520 → $570 | Maintains | Buy | |||
10/11/2024 | 1.55% | JP Morgan | $495 → $575 | Maintains | Overweight | |||
10/08/2024 | -7.28% | RBC Capital | $515 → $525 | Maintains | Outperform | |||
10/01/2024 | -16.11% | Evercore ISI Group | $410 → $475 | Maintains | In-Line | |||
08/28/2024 | -12.76% | BTIG | $469 → $494 | Maintains | Buy | |||
08/22/2024 | -1.1% | Citigroup | $512 → $560 | Maintains | Buy | |||
08/02/2024 | -9.93% | Redburn Atlantic | $380 → $510 | Upgrade | Neutral → Buy | |||
07/23/2024 | -9.93% | Barclays | $490 → $510 | Maintains | Overweight | |||
07/19/2024 | -12.58% | JP Morgan | $475 → $495 | Maintains | Overweight | |||
07/19/2024 | -16.11% | Morgan Stanley | $460 → $475 | Maintains | Equal-Weight | |||
07/19/2024 | -8.17% | Truist Securities | $515 → $520 | Maintains | Buy | |||
07/19/2024 | -17.17% | BTIG | $459 → $469 | Maintains | Buy | |||
07/19/2024 | -27.59% | Evercore ISI Group | $425 → $410 | Maintains | In-Line | |||
07/19/2024 | -16.11% | Stifel | $430 → $475 | Maintains | Buy | |||
07/19/2024 | -12.58% | Piper Sandler | $490 → $495 | Maintains | Overweight | |||
07/19/2024 | -11.17% | Baird | $487 → $503 | Maintains | Outperform | |||
07/18/2024 | -13.47% | Barclays | $430 → $490 | Maintains | Overweight | |||
07/16/2024 | -9.05% | Truist Securities | $450 → $515 | Maintains | Buy | |||
07/15/2024 | -18.94% | BTIG | $451 → $459 | Maintains | Buy | |||
07/15/2024 | -18.76% | Morgan Stanley | $375 → $460 | Maintains | Equal-Weight | |||
07/10/2024 | -9.58% | Citigroup | $462 → $512 | Maintains | Buy | |||
07/09/2024 | -13.47% | Piper Sandler | $435 → $490 | Maintains | Overweight | |||
07/02/2024 | -24.94% | Evercore ISI Group | $385 → $425 | Maintains | In-Line | |||
05/30/2024 | -11.7% | Goldman Sachs | → $500 | Initiates | → Buy | |||
04/19/2024 | -25.65% | BTIG | $412 → $421 | Maintains | Buy | |||
04/19/2024 | -23.18% | Piper Sandler | $425 → $435 | Maintains | Overweight | |||
04/19/2024 | -33.77% | Jefferies | $365 → $375 | Maintains | Hold | |||
04/19/2024 | -23% | Baird | $440 → $436 | Maintains | Outperform | |||
04/08/2024 | -24.06% | Stifel | $420 → $430 | Maintains | Buy | |||
04/03/2024 | -18.41% | Citigroup | $428 → $462 | Maintains | Buy | |||
03/15/2024 | -25.83% | Stifel | → $420 | Reiterates | Buy → Buy | |||
01/25/2024 | -31.13% | Mizuho | $350 → $390 | Maintains | Neutral | |||
01/25/2024 | -24.06% | Barclays | $385 → $430 | Maintains | Overweight | |||
01/25/2024 | -23.18% | Raymond James | $372 → $435 | Maintains | Outperform | |||
01/24/2024 | -23.71% | RBC Capital | $400 → $432 | Maintains | Outperform | |||
01/24/2024 | -25.83% | Stifel | $360 → $420 | Maintains | Buy | |||
01/24/2024 | -23.18% | Truist Securities | $390 → $435 | Maintains | Buy | |||
01/24/2024 | -24.94% | Piper Sandler | $325 → $425 | Maintains | Overweight | |||
01/19/2024 | -26.53% | Wells Fargo | $363 → $416 | Maintains | Overweight | |||
01/12/2024 | -29.36% | RBC Capital | $380 → $400 | Maintains | Outperform | |||
01/03/2024 | -34.3% | Raymond James | $310 → $372 | Maintains | Outperform | |||
12/22/2023 | -31.13% | Truist Securities | $375 → $390 | Maintains | Buy | |||
12/12/2023 | -33.77% | Truist Securities | $320 → $375 | Maintains | Buy | |||
12/04/2023 | -41.72% | Morgan Stanley | $300 → $330 | Maintains | Equal-Weight | |||
11/17/2023 | -38.19% | Stifel | $315 → $350 | Maintains | Buy | |||
11/17/2023 | -43.84% | HSBC | → $318 | Initiates | → Buy | |||
10/23/2023 | -47.02% | Morgan Stanley | $330 → $300 | Maintains | Equal-Weight | |||
10/20/2023 | -42.6% | Piper Sandler | $385 → $325 | Maintains | Overweight |
El último precio objetivo de Intuitive Surgical (NASDAQ:ISRG) fue comunicado por UBS el octubre 23, 2025. La firma de analistas fijó un precio objetivo para $600.00 que espera ISRG a rise dentro de 12 meses (un posible 5.96% upside). 43 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Intuitive Surgical (NASDAQ:ISRG) fue proporcionada por UBS, y Intuitive Surgical mantuvo su neutral calificación.
La última revisión al alza de Intuitive Surgical Inc se produjo en diciembre 2, 2024, cuando Morgan Stanley elevó su precio objetivo a $650. Morgan Stanley anteriormente tenía an equal-weight para Intuitive Surgical Inc.
La última revisión a la baja de Intuitive Surgical Inc se produjo en junio 9, 2025, cuando Deutsche Bank cambió su precio objetivo de $515 a $440 para Intuitive Surgical Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Intuitive Surgical, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Intuitive Surgical se registró el octubre 23, 2025, por lo que la próxima calificación estará disponible en torno al octubre 23, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Intuitive Surgical (ISRG) fue un mantuvo con un precio objetivo de $585.00 a $600.00. El precio actual al que cotiza Intuitive Surgical (ISRG) es de $566.25, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.